卢嘉锡讲座报告：Multifunctional Hybrid Materials and Nanostructures for Photonics, Photovoltaics, Biophotonics and Nanomedicine
更新日期：2019-06-24
题 目：Multifunctional Hybrid Materials and Nanostructures for Photonics, Photovoltaics, Biophotonics and Nanomedicine
报告人：Paras N. Prasad 教授
单 位：纽约州立大学布法罗分校
时 间：2019/6/28 15:00
地 点：化学楼四楼报告厅
－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－
附简介：
PARAS N. PRASAD, Ph.D., is SUNY Distinguished Professor of Chemistry, Physics, Electrical Engineering and Medicine; Samuel P. Capen Chair of Chemistry; and Executive Director of the Institute for Lasers, Photonics and Biophotonics. He has been named a Fellow of the National Academy of Inventors. In 2005, Scientific American named him among the top 50 science and technology leaders in the world. He has published more than 800 scientific papers, along with four field-defining monographs in Nonlinear Optics, Biophotonics, Nanophotonics, and Nanomedicine; eight edited books; and numerous patents. He has received the Peter Debye Award, Morley Medal and the Schoellkopf Medal from the American Chemical Society. Prasad is also the winner of SPIE’s highest honor of President’s Gold medal, Optical Society’s Michael Feld Biophotonics award and IEEE’s Pioneer Award in Nanotechnology in recognition of his numerous pioneering contributions to nanophotonics, biophotonics and nanomedicine. He also won a Guggenheim Fellowship, a Sloan Fellowship; the Western New York Health Care Industries Technology/Discovery Award; a SUNY Excellence in the Pursuit of Knowledge award; UB’s first Innovation Impact award; and his University’s President’s Medal. He is a fellow of the APS, OSA, and SPIE, and IEEE. He is on the Thompson Reuters “Highly Cited Researchers” list for 2014 and 2016. Prasad has received Honorary Doctorates from KTH in Sweden, the Aix-Marseille University in France, MEPhI in Russia, and Federal University of Pernambuco in Brazil. Beyond his outstanding scholastic and research achievements, his work has had substantial technological and societal impact. His technologies have produced nine spin-off companies, one of which, a publicly traded company, Nanobiotix, is now in advanced clinical trial for cancer therapy. Prasad has also mentored many students and championed young faculty members across the globe.
－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－
报告网页链接如下：Paras N. Prasad教授学术报告链接